These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 4276571)

  • 1. Proceedings: Morphological and functional changes in the rat heart after pre-treatment with isoprenaline.
    Jacobi H; van Ammon D; Lorenz D
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R39. PubMed ID: 4276571
    [No Abstract]   [Full Text] [Related]  

  • 2. Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.
    van Wijngaarden J; Monnink SH; Bartels H; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    J Cardiovasc Pharmacol; 1992 May; 19(5):741-7. PubMed ID: 1381772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by manganese of the calorigenic and cardiovascular actions of catecholamines and theophylline.
    Strubelt O; Uhl E; Back G
    Pharmacology; 1973; 10(2):88-96. PubMed ID: 4763466
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiotoxic interactions between sympathomimetic amines and ouabain.
    Lum BK; Yano SS; Yatsushiro GN
    Proc West Pharmacol Soc; 1977; 20():275-80. PubMed ID: 896835
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the mechanogram and other circulatory parameters induced by isoprenaline and adrenaline under the effect of verapamil, quinidine and adrenergic substances].
    Haas H
    Arzneimittelforschung; 1970 Apr; 20(4):501-9. PubMed ID: 5467814
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to nor-epinephrine, isoprenaline and spironolactone derivatives in normal and hypertensive rats.
    Eandi M; Ricci Gamalero S; Miocchi D
    Boll Soc Ital Biol Sper; 1979 Jul; 55(13):1252-8. PubMed ID: 508422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study.
    Loh HK; Sahoo KC; Kishore K; Ray R; Nag TC; Kumari S; Arya DS
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):233-9. PubMed ID: 17371527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of isolated rat heart cells to cardiotoxic concentrations of isoprenaline.
    Steen EM; Noronha-Dutra AA; Woolf N
    J Pathol; 1982 Jun; 137(2):167-76. PubMed ID: 7086574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with catecholamines and the cardiovascular system.
    LeBlanc J; Vallières J; Bureau M; Labrie A; Deshaies Y; Vachon C
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():527-32. PubMed ID: 4806666
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamics in the rat with isoproterenol induced cardiac hypertrophy.
    Lin YC
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):213-20. PubMed ID: 4270173
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of cardiovascular and ionic changes in pathogenesis and prevention of isoprenaline-induced cardiac necrosis.
    Strubelt O; Siegers CP
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():135-42. PubMed ID: 741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Do catecholamines increase basal metabolism?].
    Strubelt O
    Arzneimittelforschung; 1968 Jun; 18(6):724-9. PubMed ID: 5755811
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study.
    Chagoya de Sánchez V; Hernández-Muñoz R; López-Barrera F; Yañez L; Vidrio S; Suárez J; Cota-Garza MD; Aranda-Fraustro A; Cruz D
    Can J Physiol Pharmacol; 1997 Dec; 75(12):1300-11. PubMed ID: 9580216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) in experimental chloroform-epinephrine and digitalis dysrhythmias.
    Melville KI; Eu HY; Berger JM; Dookhoo A
    J Pharmacol Exp Ther; 1970 Oct; 175(1):147-56. PubMed ID: 5528538
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile.
    Charlier R; Deltour G; Baudine A; Chaillet F
    Arzneimittelforschung; 1968 Nov; 18(11):1408-17. PubMed ID: 5755904
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of isoproterenol on blood pressure and heart rate in different phases of the oestrous cycle.
    Cirić O; Susić D
    Endokrinologie; 1980 Dec; 76(3):274-8. PubMed ID: 7193571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial lipid peroxidation during isoproterenol-induced blood flow reduction in rat myocardium.
    Blasig IE; Blasig R; Löwe H
    Biomed Biochim Acta; 1984; 43(8-9):S171-4. PubMed ID: 6440536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of cardiac beta-receptors. Studies by means of dose-effect-curves of isoprenaline, propranolol and KL 255].
    Holtermann W; Lochner W
    Arzneimittelforschung; 1970 Jan; 20(1):8-12. PubMed ID: 4392501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.